Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market.
Harris was the most progressive member of the Senate during her tenure and campaigned for president in 2020 on the promise of a government takeover of the health insurance system. That same year, Walz signed a bill to cap insulin costs. Last year, he created a state-run board with the power to cap drug prices.
We can expect a Harris-Walz administration, if elected, to take steps to bring America’s biopharmaceutical industry under further government control.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
This Bipartisan Bill Would Upend America’s Pharmaceutical Industry
Sally C. Pipes
Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market.
Harris was the most progressive member of the Senate during her tenure and campaigned for president in 2020 on the promise of a government takeover of the health insurance system. That same year, Walz signed a bill to cap insulin costs. Last year, he created a state-run board with the power to cap drug prices.
We can expect a Harris-Walz administration, if elected, to take steps to bring America’s biopharmaceutical industry under further government control.
Click to read the full article in Forbes.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.